Antisense Therapeutics Ltd
ASX:ANP
Bankruptcy Probability
Antisense Therapeutics Ltd's probability of bankruptcy is 1%, making a collapse highly unlikely. The solvency score is 79/100 — a strong indicator of financial stability.
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Financial Position
A solvent company is one that owns more than it owes. Comparing the amount of cash and investments with existing debt gives an idea of the company's long-term financial health.
Interest Coverage
To determine how easily a company can pay interest on its outstanding debt, the Interest Coverage ratio is used. It represents how many times the company can pay its obligations using its operating income.
The lower the ratio, the more the company is burdened by debt expenses. When a company's interest coverage ratio is only 1.5 or lower, its ability to meet interest expenses may be questionable.
Antisense Therapeutics Ltd's probability of bankruptcy is 1%, making a collapse highly unlikely.
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Antisense Therapeutics Ltd has total debt of 48k AUD. This includes both short-term (0 AUD) and long-term (48k AUD) debt.
You can find a full breakdown on its Balance Sheet.
You don't have any saved screeners yet
